What Are Hernia Mesh Made Of? Materials Explained

Most hernia meshes are made of polypropylene, a synthetic plastic polymer that has dominated hernia repair for decades. But polypropylene is far from the only option. Surgeons today can choose from expanded polytetrafluoroethylene (ePTFE), polyester, absorbable biosynthetic polymers, meshes derived from animal or human tissue, and composites that layer different materials together. The material matters because it shapes everything from how your body heals around the implant to the risk of chronic pain, infection, or recurrence years later.

Polypropylene and Why It Became the Standard

Polypropylene is the most commonly used material for surgical mesh in hernia repair and has been for several decades.¹ It is a thermoplastic polymer, meaning it can be molded when heated and holds its shape once cooled. When knitted into a mesh, polypropylene creates a scaffold that your body’s connective tissue grows into, anchoring the repair. The material is inexpensive, easy to manufacture, strong enough to reinforce the abdominal wall, and relatively straightforward to handle in the operating room.

Polypropylene meshes come in different configurations. Some are woven from a single continuous strand of polymer (monofilament), while others use multiple thinner strands braided or twisted together (multifilament). This distinction has practical consequences beyond just texture, and we will return to it when discussing infection risk. Polypropylene mesh is designed to remain in the body permanently, and most products on the market today are large-pore knitted polypropylene.²

Other Permanent Synthetic Materials

Expanded polytetrafluoroethylene, commonly known as ePTFE, is the same base polymer found in nonstick cookware, though in mesh form it is processed into a microporous sheet. Unlike polypropylene’s open-knit structure, ePTFE has much smaller pores, which gives it a smoother surface and makes it useful in situations where the mesh will directly contact internal organs. In animal studies comparing the two, ePTFE produced less adhesion to surrounding tissue than polypropylene when placed inside the abdomen, though adhesion was still substantial.³ The tradeoff is that tissue does not grow into ePTFE as aggressively, which can mean less integration with the abdominal wall over time.

Polyester (polyethylene terephthalate, or PET) is a third permanent synthetic used in some meshes. Like polypropylene, polyester can be knitted into open-weave structures. One analysis of meshes explanted from a single patient found that polyester and ePTFE showed only slight chemical changes after years in the body, while polypropylene showed significant oxidation. However, both ePTFE and polyester still triggered an active foreign body response, with giant cells and plasma cells surrounding the implant.⁴ All three permanent synthetics provoke some degree of chronic inflammation; they differ mainly in how much and in what pattern.

Mesh Weight and Pore Size

When surgeons talk about “lightweight” versus “heavyweight” mesh, they are referring to the density of the material, measured in grams per square meter. A heavyweight polypropylene mesh sits around 95 g/m², while lightweight versions are roughly a third of that, in the range of 34 to 36 g/m².⁵ Lightweight meshes achieve their lower density by using thinner filaments and wider pores, which makes them substantially more flexible. In biomechanical testing, lightweight meshes flexed several times more than heavyweight meshes at the same opening size.⁶

The idea behind lightweight mesh is that less foreign material means less inflammation, less stiffness after healing, and a more comfortable result for the patient. A retrospective comparison found that after 12 months, patients with lightweight polypropylene mesh tended to report fewer limitations, better comfort, and improved general health compared to those with heavyweight mesh, though short-term outcomes at 30 days were similar.⁵

Pore size is a separate but related consideration. In polypropylene meshes, pores of 1.0 × 1.0 mm or smaller are considered “small-pored,” while anything larger is “large-pored.”⁷ Larger pores allow more tissue to grow through the mesh, which generally improves integration with the body’s own tissue and reduces the density of inflammatory cells concentrated at the mesh surface. The trend over the past two decades has been strongly toward large-pore, lightweight designs.

Absorbable Synthetic Meshes

A newer class of mesh is designed to do its job and then disappear. These absorbable biosynthetic meshes are made from polymers that the body can break down over time. The most studied is poly-4-hydroxybutyrate (P4HB), which degrades through hydrolysis, meaning water slowly breaks the polymer chains apart. P4HB meshes are designed to be absorbed within roughly 12 to 18 months, during which time the body replaces the scaffold with its own tissue.²

The appeal is straightforward: once the mesh degrades, there is no foreign body left to cause chronic inflammation, stiffness, or late infections. P4HB breaks down into water and carbon dioxide with neutral byproducts, and long-term follow-up data has suggested lower complication and infection rates compared to both permanent synthetic mesh and porcine-derived biologic mesh in complex abdominal wall reconstruction.⁸ The gradual transfer of mechanical load from the dissolving scaffold to the newly formed tissue is a key part of the design concept: the mesh supports the repair early on, then hands off responsibility to your own abdominal wall as it strengthens.

These products are not universally adopted yet. They cost more than polypropylene, and some surgeons remain cautious about whether the body’s replacement tissue will be strong enough long-term, particularly in large or complex hernias. But the evidence so far has been encouraging enough that absorbable biosynthetic meshes are gaining a significant foothold.

Biologic Meshes Made From Animal or Human Tissue

Biologic meshes take an entirely different approach. Instead of synthetic polymers, they are made from tissue harvested from humans or animals, processed to remove cells while preserving the underlying structural framework called the extracellular matrix. The resulting scaffold is essentially a sheet of collagen and other structural proteins that the body can recognize and gradually remodel into its own tissue. Common source tissues include human cadaveric skin (the basis for products like AlloDerm), porcine small intestinal submucosa (SIS), and bovine or porcine dermis.

The processing step matters enormously. Biologic meshes fall into two broad camps: non-crosslinked and crosslinked. Non-crosslinked biologics like AlloDerm and SIS are designed to be remodeled by the body. In animal studies, these materials showed earlier cell infiltration, new blood vessel growth, and new collagen deposition compared to crosslinked alternatives.⁹ The non-crosslinked scaffolds were gradually absorbed and replaced with the patient’s own tissue. By contrast, crosslinked biologics like Permacol and CollaMend are chemically treated to resist breakdown. They persist in the body much longer, resisting enzymatic degradation, but at the cost of slower or absent remodeling.¹⁰

At longer time points, crosslinked biologics started catching up to non-crosslinked materials in some measures of tissue integration. By 12 months, crosslinked materials showed results more comparable to non-crosslinked ones for many of the features evaluated in animal models.¹¹ Still, the fundamental choice between the two strategies remains: do you want a scaffold that is replaced by the body quickly, or one that persists and provides durable structural support for longer?

A newer hybrid approach embeds a synthetic polymer within a decellularized tissue matrix, aiming to combine the biological compatibility of a tissue scaffold with the mechanical reliability of a synthetic reinforcement.¹² In animal testing, these reinforced tissue matrices showed tissue integration, functional remodeling, and a relatively mild inflammatory response, essentially splitting the difference between fully synthetic and fully biologic products.¹³

Composite and Barrier-Coated Meshes

One persistent problem with placing polypropylene mesh directly against internal organs, especially the intestines, is adhesion formation. When tissue sticks to the mesh surface, it can cause bowel obstruction, chronic pain, and complications if you ever need another surgery. Composite meshes address this by layering an anti-adhesion barrier onto one side of the mesh while keeping the tissue-integrating surface on the other.

The anti-adhesion side typically faces the organs and is made from a material that discourages tissue attachment. Common choices include oxidized regenerated cellulose (ORC), polycaprolactone (PCL), and various absorbable coatings. One lab-developed composite layered oxidized regenerated cellulose with polycaprolactone onto polypropylene mesh using electrospinning, producing a two-sided design where one side resists adhesion and the other promotes tissue ingrowth.¹⁴ Another approach uses a degradable elastomer coating enhanced with antifouling molecules called zwitterions, which in animal testing reduced both the extent and strength of adhesions by roughly 90% compared to uncoated polypropylene.¹⁵

The barrier side is usually designed to absorb over weeks to months, by which time a layer of the body’s own tissue has formed between the mesh and the organs. The structural polypropylene side remains permanently. This “best of both worlds” strategy is widely used in laparoscopic repairs where the mesh sits inside the abdominal cavity, directly next to the bowel.

The Chronic Inflammation Problem

No implanted material is truly invisible to the immune system. Even polypropylene, which was long marketed as biologically inert, triggers a chronic inflammatory response that can persist for years. An early histological study of explanted meshes found significant differences among materials: polypropylene provoked the highest volume of inflammatory cells, while expanded PTFE and polyester produced less inflammation. Even in meshes that had been in place for extended periods, macrophages remained active at the interface between the material and surrounding tissue.¹⁶

More recent research has fleshed out the picture. Even in patients who report no symptoms, polypropylene mesh implants show inflammatory granulomas dominated by monocyte-derived macrophages expressing high levels of activation markers. In a mouse model, the myeloid cell accumulation that started immediately after mesh placement showed no substantial decrease for up to 90 days. The inflammatory reaction included complement activation, cytokine production, and increasing antibody deposition over time around the implant, suggesting that the body’s immune response to permanent synthetic mesh is not a brief settling-in period but an ongoing process.¹⁷

This persistent inflammation is part of what drives the shift toward lightweight meshes, absorbable materials, and biologic scaffolds. Less foreign material left behind generally means a smaller inflammatory burden over the long term.

What Happens to Polypropylene Inside the Body Over Years

The claim that polypropylene is permanently stable once implanted turns out to be an oversimplification. Multiple studies of explanted meshes have documented degradation changes including oxidation, surface cracking, reduced melting temperature, loss of mass, and decreased compliance of the material.¹⁸ The leading theory is that free radicals produced by the inflammatory cells surrounding the mesh attack the polymer chains, breaking them down gradually through oxidation.

Microscopic analysis of explanted meshes has confirmed that a continuous layer of degraded polypropylene forms at the surface of mesh fibers over time, detectable by its ability to absorb dyes in the tiny pores created by the degradation. Inflammatory cells were found trapped within fissures in the degraded material, and the degradation layer grew progressively thicker the longer the mesh remained in the body. Cracking of this degraded layer contributes to clinically relevant mesh stiffening and deformation.¹⁹

The broader literature describes a range of degradation mechanisms including depolymerization, crosslinking, oxidative degradation by free radicals, additive leaching, hydrolysis, stress cracking, and mesh shrinkage. These chemical changes lead to visible fiber damage and eventual loss of structural integrity through embrittlement.²⁰ None of this means that every polypropylene mesh will fail, as the majority of repairs remain intact for the life of the patient. But the notion that polypropylene is an inert, unchanging implant no longer holds up to scrutiny.

How Mesh Structure Affects Infection Risk

Mesh infections, while relatively uncommon, are one of the most dreaded complications of hernia repair because they often require surgical removal of the implant. The material and physical structure of the mesh play a role in how vulnerable it is to bacterial colonization.

Multifilament meshes, which are woven from bundles of fine strands, create tiny crevices between the individual fibers. These niches give bacteria a place to hide from the immune system and from antibiotics. Research has shown that hydrophobicity and the presence of these sheltering niches in multifilament meshes contribute most to increased biofilm growth.²¹ By contrast, monofilament meshes with larger pores leave bacteria more exposed to immune cells and allow better antibiotic penetration.

Biologic meshes are not automatically safer in this regard. In vitro testing found that some biologic materials like SIS (porcine small intestinal submucosa) actually showed high bacterial affinity, with Staphylococcus species readily colonizing the porous matrix. Among the materials tested, crosslinked porcine dermis (Permacol) yielded the lowest bacterial loads.²² The takeaway is that “biologic” does not automatically mean “more resistant to infection.” The specific material, its porosity, and its surface chemistry all matter.

When Mesh Positioning Goes Wrong

Even the best material can cause problems if the biomechanical match between the mesh and the abdominal wall is poor. Your abdominal wall is not a simple flat sheet; it stretches and contracts in different directions as you breathe, bend, and exert force. If a mesh is oriented in a way that does not match the natural stretch patterns of the surrounding tissue, constant shear stress builds up at the interface. In animal experiments where mesh was implanted with a directional mismatch, the mesh stretched in one direction by about 11% while contracting in the perpendicular direction by about 13%, causing lopsided connective tissue formation and loss of the abdominal wall’s natural elasticity. Some animals developed margin hernias where the lower edge of the mesh shifted into the defect area.²³ This is one reason lightweight, flexible meshes are gaining favor: they are more forgiving of slight misalignment during surgery.

Drug-Eluting and Experimental Meshes

The frontier of hernia mesh research is moving well beyond choosing a static material. Several groups are developing meshes that actively release drugs at the surgical site. The logic is simple: if infection and inflammation are the two biggest material-related complications, why not build the treatment into the mesh itself?

One approach loads antibiotics directly into electrospun polymer fibers. Researchers have embedded antibacterial agents and broad-spectrum antibiotics like levofloxacin into polycaprolactone nanofibers and demonstrated that these drug-loaded fibers successfully inhibited growth of common wound pathogens.²⁴ The fiber structure allows for controlled release, delivering the drug steadily over days or weeks rather than in a single burst. Integrating both antibiotic and anti-inflammatory drug delivery into mesh designs could address multiple complications at once.²⁵

On the materials side, experimental meshes are incorporating substances that would have sounded exotic a decade ago. Electrospun meshes made from polylactic acid combined with silk fibroin, a protein from silkworm cocoons, have shown promising physical properties and biocompatibility in early testing while being cheap to produce.²⁶ Another team has gone further, 3D-printing a composite mesh that integrates chitosan, polylactic acid, and a recombinant protein inspired by spider silk, designed to promote tissue regeneration from within.²⁷ These are all in preclinical stages and years away from routine use, but they illustrate where the field is heading: away from inert structural patches and toward bioactive scaffolds that participate in healing.

How Surgeons Choose a Material

Given the range of options, the choice of mesh material is not one-size-fits-all. It depends on the hernia’s location, size, and complexity, the degree of contamination at the surgical site, whether the mesh will contact the bowel, and the patient’s history of prior repairs or infections.

Clean inguinal hernias: Lightweight polypropylene remains the workhorse for straightforward groin hernias, offering a long track record, low cost, and good outcomes for most patients.
Intraperitoneal placement: When mesh must go inside the abdominal cavity next to the bowel, composite meshes with an anti-adhesion barrier or ePTFE are typically preferred to reduce the risk of bowel sticking to the implant.
Contaminated or infected fields: Biologic meshes are sometimes chosen when there is active infection or contamination, because they can be vascularized and resist infection better in theory than permanent synthetics. Absorbable biosynthetic mesh like P4HB is also gaining ground in these settings.
Complex abdominal wall reconstruction: Larger defects with comorbidities like obesity or prior mesh failure may call for absorbable scaffolds or hybrid biologic-synthetic products, aiming for tissue remodeling rather than permanent foreign-body implantation.

No mesh material is perfect for every scenario, and the field remains divided on many of these choices. The research on long-term polypropylene degradation and chronic inflammation has not led to its abandonment, because alternatives come with their own tradeoffs: higher cost, uncertain long-term strength, or limited availability. What has changed is that surgeons and patients now have more material options than ever, and the conversation about which mesh to use is becoming more specific to the individual repair rather than defaulting to whichever polypropylene product is on the hospital shelf.